Biolyst Scientific today announced its new brand name, reflecting the integration of Electron Microscopy Sciences (EMS) and Azer Scientific. The combined company blends extensive industry knowledge with an uncommon passion to make a difference – creating clinical, research, economic, and relationship value every day.
“This is an incredibly exciting day for Biolyst Scientific, our talented team, and our long-term customers and partners,” said Rajan Kapadia, President & CEO of Biolyst Scientific, who leads the combined entity. “New frontiers in Life Sciences are creating a need for accurate data acquisition and speed of discovery – we don’t just deliver products on time, but elevate the customer experience by providing unparalleled reliability, precision, and a relentless focus on surfacing genuine solutions for the needs of the lab.”
The new name, ‘Biolyst,’ reflects the essential part the company plays in the Life Sciences discoveries that make life better for all. ‘Bio’ signals where impact is felt – in enhancing and extending life – and ‘lyst’ signifies its role as catalyst in helping clinical and research labs pursue breakthroughs with accuracy and efficiency. The EMS and Azer brand names will continue to exist as ‘power brands’ within the product portfolio.
While its broader solutions portfolio amplifies Biolyst Scientific’s impact, the company will maintain its uniquely collaborative relationship style and personalized focus to continue helping clinicians and researchers expand their discovery efforts cost-efficiently. This blend of scale and personal touch positions Biolyst as a significant partner to the most innovative clinical and research laboratories.
Since the merger was announced in August 2023, the company prioritized commercial integration to ensure customers of today and tomorrow have a seamless sales and service experience that meets their needs, tracks their growth, and promotes new discoveries. Yet – to maximize customer experience continuity – the company plans to maintain EMS and Azer websites, ERP systems, and other key touchpoints.
Biolyst Scientific is backed by private investment firm Inverness Graham.